Assesment of the Medical and Social Benefits of Incretin-Based Therapy

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.610
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Predicting Response to Incretin-Based Therapy

Research and Reports in Endocrine Disorders
2011English

Which Incretin-Based Therapy for Type 2 Diabetes?

The Lancet
Medicine
2014English

Cardiovascular Effects of the Incretin-Based Therapy: The Good, the Bad, or the Ugly?

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2015English

Incretin-Based Therapy and Risk of Acute Pancreatitis: A Nationwide Population-Based Case-Control Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2015English

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The Benefits by Far Outweigh the Potential Risks

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2013English

Role of Incretin‐based Therapy in Hospitalized Patients With Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2019English

Incretin-Based Therapy: A Powerful and Promising Weapon in the Treatment of Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2011English

Oral Galactose Provides a Different Approach to Incretin-Based Therapy of Alzheimer's Disease

Journal of Neurology & Neuromedicine
2018English

Cardiovascular Effects of Incretin Therapy in Diabetes Care

Metabolic Syndrome and Related Disorders
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy